###begin article-title 0
###xml 29 35 29 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 0 25 <span type="species:ncbi:35265">Porcine adenovirus type 3</span>
Porcine adenovirus type 3 E1Blarge protein downregulates the induction of IL-8
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 471 477 471 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 516 522 516 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 716 722 712 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 836 842 828 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
Replication-defective (E1-E3 deleted) adenovirus vector based gene delivery results in the induction of cytokines including IL-8, which may contribute to the development of inflammatory immune responses. Like other adenoviruses, E1 + E3 deleted porcine adenovirus (PAdV) 3 induces the production of IL-8 in infected cells. In contrast, no IL-8 production could be detected in cells infected with wild-type or mutant PAdV-3s containing deletion in E1A + E3 (PAV211) or E1Bsmall + E3 (PAV212). Expression of PAdV-3 E1Blarge inhibited the NF-kappaB dependent transcription of luciferase from IL-8 promoter. Imunofluorescence and electrophoretic mobility shift assays suggested that constitutive expression of PAdV-3 E1Blarge inhibited the nuclear translocation of NF-kappaB and its subsequent binding to DNA. These results suggest that E1Blarge interacts with NF-kappaB to prevent transcription and down regulate proinflammatory cytokine IL-8 production.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 575 576 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 577 578 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Cytokines are important mediators of inflammation and regulators of the immune response. The inflammatory response including release of inflammatory cytokines is the first defense against viral infection. However, viruses have evolved a number of different strategies to avoid the host inflammatory responses. Large DNA viruses including poxviruses and herpes viruses [1-6] modulate cytokine action by encoding secreted forms of receptors for cytokines and chemokines. Adenoviruses modulate cytokine expression by encoding intracellular proteins, which counteract TNF-alpha [7,8].
###end p 4
###begin p 5
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 177 183 <span type="species:ncbi:9606">humans</span>
Although human adenovirus (HAdV) vectors have been utilized for gene transfer for functional studies in vivo [9,10], their therapeutic use in delivering genes to the airways of humans is limited due to the transient gene expression [11]. Earlier studies have shown that the airway administration of adenovirus vector results in the induction of non specific host responses consisting in part of neutrophil accumulation followed by mononuclear cell and macrophage accumulation. Adenovirus vector infection of airway epithelial A549 cells [12,13] or airways of macaques [14] results in rapid induction of the inflammatory cytokine IL-8, which may contribute to the inflammatory host response [12]. This induction of IL-8 production has been shown to be due to adenovirus induced activation of Raf/MAPK pathway [15]. Thus, blocking these pathways may be required for developing an efficient adenovirus vector.
###end p 5
###begin p 6
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 432 438 432 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 483 489 483 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 558 564 558 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 116 122 <span type="species:ncbi:9606">humans</span>
Porcine adenovirus (PAdV) 3, a non human adenovirus is being developed as a vector for gene delivery in animals and humans [16,17]. Availability of the complete nucleotide sequence and transcription map of PAdV-3 [18] genome has facilitated the construction of recombinant PAdV-3s [16,17,19,20] and their use as vaccine delivery vehicles [21]. Earlier, analysis of early region 1 (E1) of PAdV-3 suggested that while E1A [20] and E1Blarge [19] are essential for virus replication, E1Bsmall is not essential for virus replication [20]. Here, we report that E1Blarge can impair the induction of inflammatory cytokine IL-8 by inhibiting the NF-kappaB dependent gene transcription.
###end p 6
###begin title 7
Results and discussion
###end title 7
###begin title 8
RNase protection assay
###end title 8
###begin p 9
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 476 482 476 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 546 552 546 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 557 563 557 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1346 1352 1346 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 1516 1522 1516 1522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 1527 1533 1527 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 1578 1584 1578 1584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Earlier, induction of chemokines has been reported in adenovirus vector infected mouse renal epithelial cells [22], A549 cells [12] and HeLa cells [15], but not in U373 cells [7]. Moreover, both E1A and E3 gene products have been shown to down regulate the transcription of some chemokines [7,23]. To determine the effect of PAdV-3 E1 proteins on the induction of chemokines, HeLa cells were infected with PAV211 (E1A nt [530-1230] + E3 [nt 28112-28709] deleted), PAV212 (E1B small [nt 1460-1820] + E3 [nt 28112-28709] deleted), PAV227 (E1A + E1Bsmall + E1Blarge [nt 524-3274] + E3 [nt 28112-28709] deleted) or PAV300 (E3 [nt 28112-28709] deleted) at an MOI of 100 infectious units [24]. The construction and characterization of the mutant PAdV-3s has been described [19,20]. At 6 h post infection, the cells were harvested and processed for the isolation of total RNA using TRIZOL (Invitrogen) as per manufacturer's protocol. RNase protection assay was performed with the RiboQuant Muti-Probe template (BD Biosciences) set hCK-5 as per manufacturer's protocol. Autoradiographs were analyzed by a Molecular phosphoimager FX and Quantity One software (BIO-RAD). As seen in Fig. 1A, no chemokine specific transcript could be detected in the cells infected with wild-type or mutant PAdV-3 containing deletion of E3 (PAV300), E1A + E3 (PAV211) or E1Bsmall + E3 (PAV212). Interestingly, IL-8 transcript was the dominant chemokine gene induced in the cells infected with recombinant PAdV-3 containing deletion of E1A + E1Bsmall + E1Blarge + E3 (PAV227). These results suggest that E1Blarge protein inhibit the expression of inflammatory cytokine IL-8.
###end p 9
###begin p 10
###xml 10 16 10 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PAdV-3 E1B<sup>large </sup>inhibit IL-8 production. (A) </bold>
###xml 314 318 314 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B).</bold>
###xml 350 355 <span type="species:ncbi:9606">human</span>
PAdV-3 E1Blarge inhibit IL-8 production. (A) Total RNA isolated at 6 h post infection of HeLa cells with indicated viruses was analyzed by RNA protection assay using RiboQuant Multi-Probe template set hCK-5. The protected band indicated by the label on the right migrate faster that undigested probes, as expected.(B).HeLa cells transfected with the human IL-8 promoter containing a NF-kappaB recognition sequence, cloned upstream from a luciferase reporter cDNA in the presence of plasmid pCDNA3.1 or pCDNA3.1-pE1BL were assayed for luciferase activity (expressed as relative light units [RLU]). The error bars represent the standard error of mean of triplicate samples.
###end p 10
###begin title 11
Luciferase reporter assay
###end title 11
###begin p 12
###xml 187 189 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 363 369 355 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 394 396 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 530 535 522 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large</sup>
###xml 731 736 723 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large</sup>
###xml 889 895 881 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
Since increased expression of proinflammatory chemokines including IL-8, in response to various stimuli including adenovirus vectors can be upregulated by NF-kappaB transcription factor [22], we employed luciferase reporter assay to examine the inhibition of transcriptional activation of IL-8 promoter (containing consensus sequence for NF-kappaB binding) by E1Blarge protein. As seen in Fig. 1B, reduced levels of the luciferase activity were obtained when phIL8-Luc DNA was cotransfected with pCDNA3.1-pE1BL DNA (expressing E1Blarge). In contrast, significant levels of luciferase activity were detected when phIL8-Luc DNA was cotransfected with pCDNA3.1 DNA showing that the competition for transcription factors binding to E1Blargeexpression vector did not nonspecifically reduce the activity of luciferase reporter gene. The results of the reporter gene expression indicated that E1Blarge reduced the NF-kappaB activated gene expression and was responsible for the observed inhibition of inflammatory cytokine IL-8 production.
###end p 12
###begin title 13
###xml 3 9 3 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
E1Blarge inhibits the translocation of NF-kappaB to the nucleus
###end title 13
###begin p 14
###xml 147 149 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 407 409 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 458 464 442 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 628 633 608 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small</sup>
###xml 635 637 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 703 709 683 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 723 728 703 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large</sup>
###xml 730 732 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 787 789 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 861 863 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1028 1030 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1043 1045 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1213 1219 1169 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
NF-kappaB is a dimmer of two heterologous proteins (p65 and p50) held in an inactive complex by an endogenous inhibitor IkappaB, in the cytoplasm [25]. After cell activation, IkappaB is phosphorylated and subsequently degraded releasing NF-kappaB, which translocates to the nucleus where it binds to the enhancer elements upstream from the transcriptional initiation site of proinflammatory cytokine genes [25]. In order to determine if the expression of E1Blarge alters the translocation of NF-kappaB to the nucleus, we analyzed the localization of p65 protein in VIDO R1 (fetal porcine retina cells expressing HAdV-5 E1A + E1Bsmall)[17] or VR1BL (fetal porcine retina cells expressing HAdV-5 E1A + E1Bsmall and PAdV-3 E1Blarge)[19] cells using immunofluorescene assay. As seen in Fig. 2A, NF-kappaB is predominantly located in the cytoplasm of VIDO R1 cells [17]. As expected, TNF-alpha treatment translocated NF-kappaB to the nucleus of VIDO R1 cells. Similarly, NF-kappaB is predominantly located in the cytoplasm of VR1BL [19] cells (Fig 2B). However, TNF-alpha treatment did not alter the cytoplasmic location of NF-kappaB in VR1BL cells. These results suggest that the constitutive expression of PAdV-3 E1Blarge is able to inhibit the translocation of NF-kappaB in TNF-alpha treated VR1BL cells.
###end p 14
###begin p 15
###xml 0 23 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of NF-&#954;B</bold>
###xml 107 113 103 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 436 440 415 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 455 459 434 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 306 310 <span type="species:ncbi:9925">goat</span>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
Expression of NF-kappaB. The cells constitutively expressing (VR1BL) or not expressing (VIDO R1) PAdV-3 E1Blarge were treated with TNF-alpha. After 15 min, the cells were fixed with 100% methanol and analyzed by indirect immunostaining with anti- NF-kappaB p65 antibody followed by Cytrade mark conjugated goat anti-mouse secondary antibody. Finally, the cells were incubated with DAPI and visualized using Zeiss AxioVision microscope. (A) VIDO R1 cells, (B) VR1BL cells. DAPI (blue); NF-kappaB p65 (red).
###end p 15
###begin title 16
###xml 3 9 3 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
E1Blarge affects the NF-kappaB binding to oligonucleotides containing NF-kappaB consensus sequence
###end title 16
###begin p 17
###xml 48 54 48 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 160 162 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 163 165 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 584 586 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 745 746 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2033 2039 1977 1983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 1423 1428 <span type="species:ncbi:9823">swine</span>
In order to investigate the effect of PAdV-3 E1Blarge protein on binding of NF-kappaB protein to an oligonucleotide containing the IL-8 NF-kappaB DNA sequence [26,27], initially, we analyzed the nuclear extracts from transfected and nontransfected cells by electrophoretic mobility shift assay (EMSA). HeLa cells were transfected either with plasmid pCDNA3.1 DNA or with plasmid pcDNA3.1-pE1BL DNA as described above. At 48 h post transfection, the cells were left untreated or treated with TNF-alpha for 30 min before HeLa cell nuclear lysates were prepared as described previously [28]. The nuclear extracts were analysed by EMSA using labeled oligonucleotides containing wild-type NF-kappaB or mutant NF-kappaB. The results are shown in Fig. 3. As expected TNF-alpha treatment induced the binding of NF-kappaB to its consensus binding sequence in nuclear lysates of the cells transfected with plasmid pCDNA3.1 (panel A I). No such binding was observed following TNF-alpha treatment of the cells transfected with pCDNA3.1-pE1BL. Super shift assays using anti-NF-kappaB p65 antibodies demonstrated a supershifted band in the nuclear extracts of cells transfected with pCDNA3.1 DNA (panel A II). No such band could be observed when mutant NF-kappaB oligonucleotides were used as a probe with the nuclear extracts of the cells transfected with pCNDA3. or pCDNA3.1-pE1BL DNAs (panel A III). To further confirm these results, swine testicular (ST) cells were infected with wild-type or mutant PAdV-3s. At 6 h post infection, the infected cells were collected and the nuclear cell extracts prepared as described above. The nuclear extracts were analyzed by EMSA using wild-type or mutant NF-kappaB probe. As expected, NF-kappaB binding to oligonucleotides containing NF-kappaB consensus sequence could be detected in the nuclear extracts of the cells infected with PAV227 (Panel BI). No such binding could be detected when mutant NF-kappaB sequence was used with the nuclear extracts in EMSA (Panel BII). These results confirmed that E1Blarge (panel C) mediated the inhibition of NF-kappaB translocation to the nucleus of the cell, hence preventing the NF-kappaB binding to NF-kappaB consensus sequences in the nucleus.
###end p 17
###begin p 18
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EMSA of nuclear extracts. (A)</bold>
###xml 317 321 309 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 463 467 451 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
EMSA of nuclear extracts. (A). Nuclear extracts from the plasmid transfected cells (I, II, III) incubated with radiolabeled oligonucleotide probe(s) containing wild-type (I, II) or mutant (III) NF-kappaB motif from human IL-8 promoter [30] with (II) or without (I) immunoprecipitation with anti- NF-kappaB p65 serum. (B) Nuclear extracts from mock infected or virus infected cells containing wild-type (I) or mutant (II) NF-kappaB motif from human IL-8 promoter. (C) Schematic diagram showing deletion of the regions in PAV211, PAV212 and PAV227 [19,20].
###end p 18
###begin title 19
Conclusion
###end title 19
###begin p 20
###xml 48 54 48 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 269 275 265 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 391 397 379 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 522 528 502 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 571 572 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 773 775 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 824 830 792 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 831 833 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 974 980 942 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 686 711 <span type="species:ncbi:10497">African swine fever virus</span>
In summary, we have demonstrated that PAdV-3 E1Blarge protein downregulates the induction of proinflammatory cytokine IL-8 by inhibiting the NF-kappaB dependent gene transcription from human IL-8 promoter. Moreover, immunofluorescence and EMSA data suggest that the E1Blarge protein inhibits the nuclear translocation of NF-kappaB by interacting with NF-kappaB. One possible mechanism of E1Blarge action could be to act as IkappaB homolog and retain the ability to bind, and inactivate NF-kappaB. Interestingly, PAdV-3 E1Blarge shows 20% identical and 38% homology (Fig. 4) at the amino acid level to porcine IkappaB protein (GenBank Accession # ). Similar homology is reported between African swine fever virus encoded IkappaB (A238L) protein and porcine IkappaB protein [29]. Alternatively, the nuclear localization of E1Blarge [19] could have direct inhibitory effect on IL-8 transcription. These results suggest that the construction of adenovirus vectors to include E1Blarge expression cassettes will improve the efficacy and safety of such vectors.
###end p 20
###begin p 21
###xml 15 21 15 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 0 36 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Homology of E1B<sup>large </sup>to I&#954;B&#945;</bold>
###xml 119 125 99 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
Homology of E1Blarge to IkappaBalpha. Alignment of porcine IkappaBalpha (pIkappaB; GenBank Accession # ) and PAdV-3 E1Blarge (pE1BL: GenBank Accession # ). Shaded residues are identical between pIkappaB and pE1BL. Lines shown above denote the five repeats of ankyrin consensus sequence in IkappaBalpha.
###end p 21
###begin title 22
Methods
###end title 22
###begin title 23
Viruses and cells
###end title 23
###begin p 24
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 186 192 186 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">small </sup>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 449 453 <span type="species:ncbi:9913">calf</span>
Recombinant PAdV-3 bearing deletions in the E1 region were generated as described previously [20]. PAV211 contains deletions in the E1A + E3 regions, PAV212 contains deletions in the E1Bsmall + E3 regions, PAV227 contains deletions in E1 + E3 regions and PAV300 contains deletion in E3 region. Viruses were propagated and titrated as described [19,20,24]. HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS).
###end p 24
###begin p 25
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNase protection assays</italic>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
RNase protection assays. Monolayers of HeLa cells (1X105/well) in 12 well plate were infected with wild-type or mutant PAdV-3s at a MOI of 100. At 6 h post infection, HeLa cells were harvested and processed for total RNA using TRIZOL (Invitrogen) as per manufacturer's protocol. RNase protection assay was performed with the RiboQuant Multi-Probe template (BD Biosciences) set hCK-5 as per manufacturer's protocol. Autoradiographs were analyzed by phosphoimaging with a Personal FX phosphoimager and Quantity One software (Bio-Rad).
###end p 25
###begin title 26
Plasmid construction
###end title 26
###begin p 27
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 167 173 167 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GCTAGC</bold>
###xml 288 294 288 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CTCGAG</bold>
###xml 630 636 630 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 702 708 702 708 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TGCTAG</bold>
###xml 826 832 826 832 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CTCGAG</bold>
###xml 1139 1145 1139 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">large </sup>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 1171 1192 <span type="species:ncbi:10359">human cytomegalovirus</span>
The 181-bp human IL-8 promoter sequence (-135 to +46) was PCR amplified from the genomic DNA [26,27] derived from HeLa cells using the primers: hIL8 (-135) Fw: 5'-CAATGCTAGCG AAGTGTGATGACTCAGG TT-3', which contains a NheI restriction enzyme site (bold letters), and hIL8 (+46) Bw: 5'-CGTTCTCGAGA AGCTTGTGTGCTCTGCTGT-3' containing a XhoI restriction enzyme site (bold letters). The PCR product was digested with NheI-XhoI and ligated to NheI-XhoI digested plasmid pGL3-Basic (Promega) creating plasmid phIL8-Luc. The plasmid phIL8-Luc contains luciferase gene under the control of IL-8 promoter. Similarly, the coding region of E1Blarge gene was PCR amplified using the primers: [PE1BL (NheI) Fw: 5'-CAGTGCTAGCATGTTCCCTGC TGGAGGCGC-3', which contains a NheI restriction enzyme site (bold letters), and PE1BL (XhoI) Bw: 5'-GTCA CTCGAGTC AGTCATC G TCATCGCTGAA-3' containing a XhoI restriction enzyme site (bold letters)] and PAdV-3 genomic DNA as a template. The PCR product was digested with NheI-XhoI and ligated to NheI-XhoI digested plasmid pCDNA3.1(-) (Invitrogen) creating plasmid pCDNA3.1-pE1BL. The plasmid pCDNA3.1-pE1BL contains E1Blarge gene under the control of human cytomegalovirus immediate early (HCMV IE) promoter.
###end p 27
###begin title 28
Luciferase assay
###end title 28
###begin p 29
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
HeLa cells (1x105 cells/well) were plated in 12-well plate and incubated overnight. Tansfections were carried out using 0.5 mug of each plasmid [(phIL8-Luc, pCDNA3.1-pE1BL] or [phIL8-Luc, pCDNA3.1])/well (in triplicate) using 5 mul of lipofectin (Invitrogen), followed by incubation for 5 h in Opti-MEM (Invitrogen). After adding FCS to each well to give a final concentration of 1%, the cells were incubated for 18 h at 37degreesC. Finally, the cells were washed with PBS and lysed in 200 mul of 1x lysis buffer (Luciferase reporter assay kit, BD Bioscience). Luciferase activity was determined using 50 mul of cell extract and was read using a TD-20/20 luminomitor (Turner Designs).
###end p 29
###begin title 30
Immunofluorescent Microscopy
###end title 30
###begin p 31
###xml 9 11 9 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 531 535 <span type="species:ncbi:9925">goat</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
VIDO R1 [17] and VR1BL [19] cells plated on glass coverslips were untreated or treated with 10 ng/ml TNF-alpha (R&D System). At 15 min post treatment, the cells were washed with PBS, fixed and permeabilized by incubating with methanol/acetone (1:1) at -20degreesC for 15 min. The cells were rehydrated with PBS and incubated for 1 hour in a 1:200 dilution of monoclonal antibody specific for the p65 subunit of NF-kappaB factor (Santa Cruz). The cells were washed three times with PBS and incubated with 1: 800 diluted Cy3-labeled goat anti-mouse antibody (Jackson Laboratory) for 30 min at room temperature. Finally, the cells were washed three times in PBS before incubating with DAPI at concentration of 1mug/ml (Roche) for 5 min. Fluorescence was examined and photographed using a Carl Zeiss Axiovert 200 M inverted fluorescent microscope.
###end p 31
###begin title 32
Electrophoretic mobility shift assays (EMSA)
###end title 32
###begin p 33
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 655 656 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 985 996 949 960 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TGGAATTTCCT</bold>
###xml 1084 1085 1044 1045 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1085 1087 1045 1047 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 1085 1087 1045 1047 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TT</underline></bold>
###xml 1087 1092 1047 1052 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AATTT</bold>
###xml 1092 1094 1052 1054 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AA</underline>
###xml 1092 1094 1052 1054 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>AA</underline></bold>
###xml 1094 1095 1054 1055 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1100 1102 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1133 1135 1089 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
HeLa nuclear lysates were prepared as described previously ([28]. Briefly, the cells were washed two times with phosphate-buffered saline, resuspended in 4 pellet volumes of buffer A [(10 mM TRIS (pH 7.9), 10 mM NaCl, 1.5 mM MgCl2, 5 mM dithiothreitol (DTT), 0.5 mM phenyl-methyl sulfanyl fluoride (PMSF), and 5 mug of aprotinin, leupeptin, and pepstatin (ALP) per ml)] and incubated at 4degreesC for 1 h. The cells were lysed by three freeze/thaw cycles and centrifuged for 5 min at 2000 x g at 4degreesC. The nuclei were washed once with buffer A, resuspended in 3 pellet volumes of buffer B [(20 mM TRIS (pH 7.9), 20% glycerol, 400 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 5 mM DTT, 0.5 mM PMSF, and 5 mug of ALP per ml)] and incubated at 4degreesC for 30 min. The nuclear lysates were collected after centrifugation for 30 min at 12,000 x g at 4degreesC and stored at -80degreesC. The oligonucleotides containing wild-type NF-kappaB (shown in boldface) motif (5'-CGTAGCCATCAGTTGCAAA TCGTGGAATTTCCTCT-3') or mutant NF-kappaB (mutated residues underlined) motif (5'CTAGGCCATCAGTTGCAAATCGTTTAATTTAATCT) [30] were end-labeled with [alpha-32P] dCTP using the Klenow fragment of DNA Polymerase I.
###end p 33
###begin p 34
Each binding reaction was assembled on ice containing 0.2 ng of double-stranded labeled probe, 10 mug of HeLa nuclear lysate from indicated samples, 0.5 mug poly(dI-dC), 10 mM Tris (pH 7.8), 50 mM NaCl, 1 mM EDTA and 3.3 mM sodium acetate. DNA-protein complexes were electrophoresed for 2 h at 150 V through 5% acrylamide gels. The gels were dried for 60 min at 80degreesC and exposed to Phosphor screens. Images were analyzed with a Molecular phosphoimager FX and the Quantity One software package (BIO - RAD).
###end p 34
###begin title 35
Competing interests
###end title 35
###begin p 36
The author(s) declare that they have no competing interests.
###end p 36
###begin title 37
Authors' contributions
###end title 37
###begin p 38
YZ designed and carried out the experiments, and helped to analyze the data. AF designed, performed and helped to analyze the EMSA experiments. SKT helped to design the study and drafted the manuscript. All authors read, made corrections and approved the final manuscript.
###end p 38
###begin title 39
Acknowledgements
###end title 39
###begin p 40
The work was supported by a grant from Natural Sciences and Engineering Research Council (NSERC) of Canada to S.K.T. Published as VIDO journal article # 457.
###end p 40
###begin article-title 41
###xml 0 12 <span type="species:ncbi:10243">Cowpox virus</span>
Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor
###end article-title 41
###begin article-title 42
Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein
###end article-title 42
###begin article-title 43
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity
###end article-title 43
###begin article-title 44
Chemokine receptors and molecular mimicry
###end article-title 44
###begin article-title 45
Sequence analysis of HindIII Q2 fragment of capripox virus reveals a putative gene encoding a G-protein coupledchemokine receptor homologue
###end article-title 45
###begin article-title 46
Molecular cloning, functional expression and signaling characteristics of a C-C chemokine receptor
###end article-title 46
###begin article-title 47
Inhibition of chemokine expression by adenovirus early region three (E3) genes
###end article-title 47
###begin article-title 48
Adenovirus proteins that subvert host defenses
###end article-title 48
###begin article-title 49
Genetically modified adenoviruses against gliomas
###end article-title 49
###begin article-title 50
Update on adenovirus and its vectors
###end article-title 50
###begin article-title 51
Antivector and antitransgene host responses in gene therapy
###end article-title 51
###begin article-title 52
Replication-deficient adenovirus induces expression of interleukin-8 by airways epithelial cells in vitro
###end article-title 52
###begin article-title 53
Infection of replication-deficient adenoviral vector enhances interleukin-8 production in small airway epithelial cells more than in large airway epithelial cells
###end article-title 53
###begin article-title 54
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of non human primates
###end article-title 54
###begin article-title 55
Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression
###end article-title 55
###begin article-title 56
Development of porcine adenovirus-3 as an expression vector
###end article-title 56
###begin article-title 57
Porcine adenovirus-3 as a helper-dependent expression vector
###end article-title 57
###begin article-title 58
###xml 45 70 <span type="species:ncbi:35265">porcine adenovirus type 3</span>
Nucleotide sequence and transcription map of porcine adenovirus type 3
###end article-title 58
###begin article-title 59
A recombinant E1-deleted porcine adenovirus-3 as an expression vector
###end article-title 59
###begin article-title 60
###xml 30 55 <span type="species:ncbi:35265">porcine adenovirus type 3</span>
Analysis of early region 1 of porcine adenovirus type 3
###end article-title 60
###begin article-title 61
###xml 44 49 <span type="species:ncbi:9823">swine</span>
Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics
###end article-title 61
###begin article-title 62
Adenovirus vector induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB
###end article-title 62
###begin article-title 63
E1A products of adenoviruses reduce the expression of cellular proliferation associated genes
###end article-title 63
###begin article-title 64
###xml 43 68 <span type="species:ncbi:35265">porcine adenovirus type 3</span>
Characterization of DNA binding protein of porcine adenovirus type 3
###end article-title 64
###begin article-title 65
IkappaB-NF-kappaB structures at the interface of inflammation control
###end article-title 65
###begin article-title 66
###xml 25 30 <span type="species:ncbi:9606">human</span>
Genomic structure of the human monocyte derived neutrophil chemotactic factor IL-8
###end article-title 66
###begin article-title 67
Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway
###end article-title 67
###begin article-title 68
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
###end article-title 68
###begin article-title 69
###xml 22 47 <span type="species:ncbi:10497">African swine fever virus</span>
An homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages
###end article-title 69
###begin article-title 70
Transcriptional activation of the interleukin-8 gene by respiratory Syncytial virus infection in alveolar epithelial cells: Nuclear translocation of RelA transcription factor as a mechanism producing airway mucosal inflammation
###end article-title 70

